hylander: I saw this from another forum, and offer it for

New Post Public Reply Private Reply Replies (3) Message Board
FanMail hylander #28123
358
hylander: I saw this from another forum, and offer it for your consideration. It made sense to me.
If you look at the history of the company, you will see that historically, GNBT made announcements about new products or services, followed a SP bump, and then the company stopped talking about the product/service permanently, and never (and I really mean never, believe it or not) mentioned the product or service again in terms of real revenues generated by the product or service. That was a successful MO for GNBT, until COVID. GNBT tried its usual "quick-pump" approach, expecting (I believe) that no company would be able to develop a deployable vaccine sooner than 4-5 years (the usual time frame), and certainly not within less than a year. That provided cover so GNBT could claim it was working on a vaccine just like everyone else, and announce agreements and memoranda of understanding with other countries and companies, pump the SP, and never have to produce anything. The plan was that COVID would fade into the background like everything before it, and no one would be the wiser. Now, the management is caught with their proverbial pants around their ankles, because other companies ARE coming and HAVE come up with effective vaccines. The only play left to GNBT at this point is to claim they are developing a "better" vaccine (not just one that works, like the "other guys", and they came up with a new scheme - trademark the name "Complete Vaccine." That way, when prospective individual investors do their DD, they see the reference multiple times, associated with GNBT. Of course, it is absolutely meaningless, because it is literally nothing more than two words stuck together and trademarked. How many individual, self-directed investors, though, actually dig down deep to get all the facts, instead of just looking at something that pops up on their screen a few times. That's what has made this truly insidious. Once some people get sucked in, the only way out is to keep praising the company in the hopes that they will be able to get their money back, and get out. Now, because the vaccine scam has not worked, the executives had to come up with something new to distract people away from this glaring failure. The "new" thing? Something they have been mentioning occasionally over the last few months - the listing of NuGenerex. But it's not NGIO, and it's not on the NASDAQ. This is deliberate. They can gin up talk about this stock simply by allowing it to trade, and denying that they knew anything about it being quoted on OTC Pink; with the true believers out there, they will get some folks to buy, even though the company has no more value than GNBT itself. Want proof? Look at GNBT recently, and ask yourself why its price has held or fallen, when GNBT owns 64% of NuGenerex, and NUGX at one point actually climbed all the way to $5.80/share. Something is not right about this. Also, if some of the shares can be traded, and trading is not stopped by the company, why can't ALL the shares be traded now? Why are only some of the shares available? The most popular explanation? Eventually, all the shares will be listed on NSADAQ, under NGIO. If that is true, and it ultimately makes no difference, then ALL the shares should be trading now, and then they all will be "uplisted" to the NASDAQ. There has to be something else dangling out there, something else that can be used in the hope of driving the price up, so that "the game goes one." Ask yourself what accomplishment took place that justified the bonuses paid to the executives. Keep an eye out for those most offensive posters on the boards, because their remarks never are direct, and usually are just explanations/excuses for why the company has not performed. It's can't ALWAYS be someone else's fault (excuse #1), and it is not ALWAYS a matter of "waiting a little longer" (excuse #2). If the company actually produced something, I would have a different attitude, and would be "singing a different tune," but history is certain, and promises are not. Look at the recent "explanations" about some "jumbo certificate," and ask yourself if that sounds like just another excuse. Now, it's time to delay again (weeks until the conference call), so that another "explanation" can be offered.
1

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 72

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 363

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 169

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 563

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 448

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 158

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 825

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 134

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading

Top 5 Most Recently Viewed Articles

MiningToken Revolutionizes Mobile Bitcoin Mining Experience

Updated Category News Views 152

MiningToken: A New Era in Mobile Bitcoin Mining The United States continues to be a leader in the cryptocurrency mining landscape, showcasing its robust market and relatively friendly regulatory environment. MiningToken, a rising player in this sector, has recently launched its cutting-edge mining app specifically designed for mobile devices. Amidst a competitive mining...

Continue Reading
Important Update for Plug Power Investors: Class Action Notice

Updated Category News Views 170

Significant Notice for Plug Power Investors Attention, investors associated with Plug Power! If you hold shares in Plug Power Inc. (NASDAQ: PLUG), there is an important deadline approaching for you to take note of. The national law firm, Faruqi & Faruqi, LLP, is currently looking into potential claims related to the company. This comes as the firm encourages those who...

Continue Reading
Stockholm Markets Rise with Notable Sector Performances

Updated Category News Views 146

Positive Trends in Stockholm Markets Recent trading sessions in Sweden's financial markets have shown encouraging signs, especially as the day drew to a close. Notably, sectors like Basic Materials, Oil & Gas, and Technology helped lift stock prices upward. An Insight into OMX Stockholm 30 Performance By the end of trading in Stockholm, the OMX Stockholm 30 index saw an...

Continue Reading
Carson Hocevar Tackles NASCAR with Zeigler Sponsor

Updated Category News Views 55

Hocevar's Return to Michigan with Zeigler Auto Group Folks, when it comes to NASCAR action this weekend, all eyes are on Carson Hocevar as he gears up for another shot at Michigan International Speedway. With the backing of Zeigler Auto Group, a name synonymous with hefty horsepower and high stakes, you know this ain't your average race. The Racing Duo: Truck and Cup...

Continue Reading
Northern Jet's New Challenger 300: Enhancing Travel Experience

Updated Category News Views 104

Northern Jet Unveils New Challenger 300 to Expand Fleet Northern Jet is excited to announce an important addition to its fleet: a brand new Challenger 300. This new aircraft brings enhanced flexibility, improving both availability and the overall travel experience for clients, including fractional owners and Private Advantage Card holders. Benefits of the Challenger 300...

Continue Reading